Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to ...

AbbVie Inc.'s Q2 2025 results showcase Skyrizi & Rinvoq's growth, strong finances, and a promising pipeline. Click for my ...

AbbVie, the maker of Botox, Humira, and Rinvoq, will invest $195 million to expand its North Chicago manufacturing facility, ...

AbbVie, a global leader in life sciences, announced Tuesday the company’s is investing $195 million to expand its North ...

AbbVie (ABBV) announced a $195M investment in its North Chicago, Illinois manufacturing plant to expand domestic active ...

NORTH CHICAGO Governor JB Pritzker, AbbVie, and the Illinois Department of Commerce and Economic Opportunity (DCEO) today ...

AbbVie (NYSE:ABBV) has revealed plans to invest $195M in its manufacturing facility located in North Chicago, Illinois, to ...

Governor JB Pritzker, AbbVie, and the Illinois Department of Commerce and Economic Opportunity (DCEO) have announced a ...

AbbVie (NYSE: ABBV) today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the U.S. This ...

As pharma companies big and small play up their U.S. investment plans during the second Trump administration, the particulars ...

AbbVie is investing $195 million in its North Chicago manufacturing plant to expand domestic drug production. It's part of the company's previously announced $10 billion U.S. capital plan, which the ...

AbbVie said on Thursday its tariff exposure is not expected to exceed that of rivals, and raised its 2025 profit forecast ...